Your session is about to expire
← Back to Search
Analgesic Non Narcotic for Bunions (MERIT-2 Trial)
MERIT-2 Trial Summary
This trial is testing a new pain medication for people who are having surgery to correct a bunion. The trial has two parts: first, different doses of the medication are tested to see what works best; then, the best dose is tested again in a larger group of people.
- Bunion
MERIT-2 Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.MERIT-2 Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Are there currently any vacancies for individuals wishing to participate in this research?
"Indeed, data published on clinicaltrials.gov verifies that this research project is presently recruiting participants. The trial was first made public on June 14th 2022 and has seen its most recent update as of July 18th 2022."
What criteria do participants need to meet in order to qualify for this research endeavor?
"This clinical trial is accepting 230 pain-stricken individuals between the ages of 18 and 75. It should be noted that potential participants have to meet certain requirements in order to qualify, such as having a Body Mass Index (BMI) below 39 kg/m2, being classified as ASA Class I or II at randomization, and consenting to sign an Informed Consent Form before taking part. Furthermore, they must plan on undergoing elective primary unilateral distal first metatarsal bunionectomy with osteotomy and internal fixation under regional anaesthesia without additional procedures or surgeries."
Is senior participation being taken into consideration for this experiment?
"This clinical trial mandates that participants must be at least 18 years of age and not exceed 75."
What potential risks do Analgesic Non Narcotic medications pose to individuals?
"Our assessment of Analgesic Non Narcotic's safety resulted in a rating of 2 on our scale, since the Phase 2 trial has generated some data regarding its security but none concerning its efficacy."
How many participants are partaking in this clinical experiment?
"The sponsor, Cali Pharmaceuticals LLC, must recruit a total of 230 eligible patients from various sites, such as Jean Brown Research in Salt Lake City and Arizona Research Center in Phoenix."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger